Corporate report

MHRA Corporate Plan 2018 to 2023

This plan outlines the Agency鈥檚 strategic direction over the next five years, including how we ensure a smooth EU exit under any scenario.

From:
Medicines and Healthcare products Regulatory Agency
Published
24 April 2018

Documents

PDF, 360 KB, 25 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Contents include the priority actions and activities which the Agency will take forward to ensure delivery of the statutory role and functions of the Agency.

Updates to this page

Published 24 April 2018

Sign up for emails or print this page

Related content